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Abstract
Background: Loss to follow-up (LTFU) in clinical trials is an important source of bias that can affect statistical power and
generalisability of findings. The aim of this paper is to assess factors associated with LTFU in the MObile Technology for
Improved Family Planning (MOTIF) trial in Cambodia and compare how the result might have varied using different
analytical methods.
Methods: Follow-up in the MOTIF trial was 86% at 4 months and 66% at 12 months. For the primary analysis, we
undertook a complete case analysis, similar to the approach used in similar trials of interventions delivered by mobile
phone to increase contraception use. We conducted an exploratory analysis and found that factors associated with LTFU
were young age, lower socio-economic status, not planning to use post-abortion contraception, availability of phone
credit and not providing additional contact numbers. We then undertook two analyses to estimate the effect of the
intervention on the primary outcome at 4 and 12 months for comparison with the complete case analysis. First, we
undertook multiple imputation, and second we conducted an analysis treating all participants’ LTFU as non-users of
contraception.
Results: Using multiple imputation, we found that the risk ratio was slightly increased at 4 months and slightly decreased
at 12 months compared with the complete case analysis. When counting all participants’ LTFU as non-users of contraception,
we observed that, compared with the complete case analysis, the risk ratio was slightly decreased at 4 months and slightly
increased at 12 months. Despite the changes in the risk ratio, use of the different analytical methods did not result in an effect
using the complete case analysis becoming statistically significant or vice versa.
Conclusion: Future studies assessing contraception use might anticipate increased attrition amongst younger participants,
those of lower socio-economic status or those who do not provide additional contact details. Attrition could be reduced by
collecting as many contact details as possible, by providing incentives and possibly by enhanced counselling to groups at
higher risk of LTFU on recruitment. Multiple imputation should be considered in addition to complete case analysis if LTFU not
missing at random is expected or observed.
Trial registration: ClinicalTrials.gov, NCT01823861. Registered on 30 March 2013.
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Background
Loss to follow-up (LTFU) in clinical trials is an important
source of bias that can affect statistical power and general-
isability of findings, and trials with large LTFU can be
downgraded in systematic reviews. Systemic differences in
LTFU between groups can result in attrition bias [1].
Successful follow-up requires participants to be found
and also willing to participate with the data collection
procedure [2]. LTFU can be classified as missing at ran-
dom (MAR) or not missing at random (NMAR), such as
increased attrition in younger people. In this situation a
complete case analysis, restricted to participants with
available follow-up data, may produce a biased estima-
tion of the true effect. A common approach to dealing
with missing outcome data is to impute outcomes and
treat them as if they were real measurements, known as
multiple imputation [3]. The aim of this paper is to
assess factors associated with LTFU in the MObile Tech-
nology for Improved Family Planning (MOTIF) trial in
Cambodia and compare how the result might have var-
ied using different analysis methods.
Main text
For the MOTIF trial, the primary outcome—self-re-
ported use of an effective contraceptive—was assessed
by attempting to contact participants by phone at 4 and
12 months. We used evidence-based methods to try to
reduce the chance of LTFU, such as collecting as many
possible phone numbers on recruitment, including those
of friends or family members, with consent of the par-
ticipant [4, 5]. At least three attempts were made to con-
tact participants by phone. If it was not a convenient
time for the participant to talk, another time would be
arranged. At the time of the trial, few participants used
email, there was not a functioning postal system in rural
areas in Cambodia, and we had limited resources with
which to visit participants’ homes. At 4 months we ob-
tained primary outcome data from 431 participants
(86%). Amongst the 69 clients LTFU, 6 withdrew, and
we were unable to contact 63 participants. At 12 months
we obtained primary outcome data from 328 partici-
pants (66%). Amongst the 172 clients LTFU, 8 withdrew,
and research assistants were unable to contact 164
participants.
For the primary analysis we undertook a complete case
analysis, similar to the approach used in similar trials of
interventions delivered by mobile phone to increase
contraception use [6, 7]. Using a complete case analysis,
we found that the intervention increased self-reported
use of an effective contraception method at 4 months
post-abortion (64% vs. 46%; risk ratio [RR] 1.39, 95% CI
1.17–1.66; p < 0.001) but not after 12 months (50% vs.
43%; RR 1.16, 95% CI 0.92–1.47; p = 0.208).
Investigating missing data
Reasons, as documented by the research assistants, for
LTFU at 12 months amongst these 164 participants were
as follows: 76 (46%) times the phone was switched off;
57 (35%) times there was an automated response that
the number was not in use and not yet re-assigned; 16
(10%) times someone else answered the phone; in 10
(6%) cases where the participant had moved abroad; in 3
(2%) cases an automated response indicated that the
phone could not receive incoming calls; and in 2 (1%)
cases the participant did not want to talk.
We conducted an exploratory analysis to identify
predictors of LTFU from the variables collected at trial
recruitment to assess whether data were MAR or
NMAR. To maximise statistical power, binary variables
were created from some of the categorical variables. First
we undertook univariable analysis to examine the crude
association between each baseline variable and LTFU,
expressed as an OR with a 95% CI. In the univariable
analysis, age < 25 years, lower socio-economic status
(SES; i.e., no access to motorised transport), not plan-
ning to use post-abortion contraception and not provid-
ing an additional friend/family contact number were
associated with LTFU at 4 months (Table 1). Age <
25 years, lower SES and usually or sometimes having
phone credit were associated with LTFU at 12 months
(Table 2). There was no evidence of differential LTFU
between those assigned to the intervention or control
arm at 4 or 12 months.
We then undertook multivariable analysis to explore
the association between variables and LTFU, controlling
for confounding, using logistic regression analysis. Age
and SES are associated with contraception use and may
be associated with seeking LTFU [8, 9]. We therefore
considered these variables as confounders in the ana-
lysis. In the multivariable analysis, age < 25 years, lower
SES, not planning to use post-abortion contraception
and not providing an additional friend/family contact
number remained as predictors of LTFU at 4 months;
LTFU was significantly increased amongst women aged
< 25 years compared with those aged > 25 years (OR
2.31; p = 0.002), amongst women without access to
motorised transport compared with women with access
to motorised transport (adjusted OR 2.44; p = 0.008),
amongst women not planning to use post-abortion
contraception compared with women planning to use it
(OR 2.34; p = 0.05), and amongst women who did not
provide additional contact numbers compared with
those who did (OR 2.40; p = 0.002) (Table 1).
At 12 months, age < 25 years, lower SES, and phone
credit remained as predictors of LTFU; LTFU was sig-
nificantly increased amongst women aged < 25 years
compared with those aged > 25 years (OR 1.59; p =
0.023), amongst women without access to motorised
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transport compared with women with access to
motorised transport (OR 2.04; p = 0.009), and amongst
women who usually (OR 1.85; p = 0.014) or sometimes
(OR 1.59; p = 0.046) had phone credit compared with
women who always had phone credit (Table 2).
We then undertook two different analyses to compare
with the complete case analysis (Table 3). First, we
undertook multiple imputation to estimate the effect of
the intervention on the primary outcome at 4 and
12 months. This involved replacing each missing pri-
mary outcome value with a plausible imputation based
on the characteristics of missing values observed [10].
Because LTFU was NMAR, variables associated with
LTFU were used in the multiple imputation model.
Thus, logistic regression with the predictor variables age
group, SES, post-abortion family planning intentions and
whether an additional friend or family contact was pro-
vided was used for univariate imputation of the outcome
at 4 months and the predictor variables age group, SES
and phone credit for imputation of the outcome at
12 months. Multiple imputation was conducted separ-
ately for the outcomes at 4 and 12 months with 100 im-
puted datasets created for each outcome, respectively.
Using multiple imputation, the intervention also showed
an effect at 4 months (63% vs. 45%; RR 1.42, 95% CI
1.19–1.69; p = 0.001) but not at 12 months (48% vs. 43%;
RR 1.12, 95% CI 0.89–1.40; p = 0.349). Second, we con-
ducted sensitivity analyses treating all participants LTFU
as non-users of contraception (extreme case scenario) to
estimate the effect of the intervention on the primary
outcome at 4 and 12 months [11]. In this analysis self-
reported effective contraceptive use also remained sig-
nificantly increased when we considered participants
LTFU as non-users at 4 months (54% vs. 40%; RR 1.35,
95% CI 1.12–1.63; p = 0.002) but not at 12 months (34%
vs. 27%; RR 1.25, 95% CI 0.95–1.63; p = 0.106).
Table 3 shows how the effect measure varies according
to the analytical method used. Using multiple imput-
ation, we found that the RR was slightly increased at
4 months and slightly decreased at 12 months compared
with the complete case analysis. When counting all
participants LTFU as non-users of contraception, we ob-
served that, compared with the complete case analysis,
the RR was slightly decreased at 4 months and slightly
increased at 12 months. Despite the changes in the RR,
use of the different analytical methods did not result in
an effect becoming statistically significant or vice versa.
Conclusion
Factors associated with LTFU in the MOTIF trial were
young age, lower SES, not planning to use post-abortion
contraception, phone credit and not providing additional
contact numbers. Reasons for LTFU amongst younger
women might be that they changed phone numbers
(could not be found) or perhaps the potential stigma of
contraceptive use in young people (no longer wanting to
participate in the trial). Younger participants were also
found to be at increased risk of LTFU in a head injury
trial [2]. LTFU amongst women of lower SES might be
due to changing phone numbers or no longer having
access to a phone. Women not planning to use contra-
ception might have been less motivated to participate in
the trial follow-up. The finding that LTFU was increased
in those not providing multiple contacts is consistent
with existing evidence [4]. Although the RR showed
slight variation using multiple imputation and counting
those LTFU as non-users, there was no significant
change in the principal findings.
Whilst this study provides some insights into factors
associated with LTFU in this trial, it may have limited
generalisability to other studies. This study had a rela-
tively small sample size and was an exploratory rather
than a pre-specified analysis.
Future studies assessing contraception use might an-
ticipate increased attrition amongst younger participants
and those of lower SES or who do not provide additional
contact details. Attrition could be reduced by collecting
as many contact details as possible, providing incentives,
and possibly providing enhanced counselling to groups
at higher risk of LTFU on recruitment [4]. Multiple im-
putation should be considered in addition to complete
case analysis if LTFU NMAR is expected or observed.
Abbreviations
LTFU: Loss to follow-up; MAR: Missing at random; MOTIF: MObile Technology
for Improved Family Planning; NMAR: Not missing at random; PAFP: Post-
abortion family planning; RR: Risk Ratio; SES: Socio-economic status
Table 3 Effect measure variation according to analytical method used
Intervention group,
n (%)
Control group,
n (%)
RR (95% CI) p Value Intervention group,
n (%)
Control group,
n (%)
RR (95% CI) p Value
4 months 12 months
Complete case
analysis
135/211 (64%) 101/220 (46%) 1.39 (1.17–1.66) <0.001 84/169 (50%) 68/159 (43%) 1.16 (0.92–1.47) 0.208
Counting participants
LTFU as non-users
135/249 (54%) 101/251 (40%) 1.35 (1.12–1.63) 0.002 84/249 (34%) 68/251 (27%) 1.25 (0.95–1.63) 0.106
Multiple imputation 158/249 (63%) 114/251 (45%) 1.42 (1.19–1.69) < 0.001 120/249 (48%) 108/251 (43%) 1.12 (0.89–1.40) 0.349
LTFU Loss to follow-up, RR Risk Ratio
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